

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.30777618 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30777618 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.06790703 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.06790703 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62750432 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.37469272 |
| 7 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.30702033 |
| 8 | N-acetylneuraminate metabolic process (GO:0006054) | 6.10975596 |
| 9 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.03752623 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.01263900 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.01263900 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.01263900 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.81719809 |
| 14 | cellular extravasation (GO:0045123) | 5.77950973 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.76817970 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.75496505 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.71512549 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.67575600 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56829214 |
| 20 | urea metabolic process (GO:0019627) | 5.46664635 |
| 21 | urea cycle (GO:0000050) | 5.46664635 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.35485066 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.23875018 |
| 24 | cysteine metabolic process (GO:0006534) | 5.23306224 |
| 25 | protein carboxylation (GO:0018214) | 5.13585598 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.13585598 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.10815704 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.10429971 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.04988243 |
| 30 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.00995226 |
| 31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.00995226 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.98313259 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96270523 |
| 34 | bile acid metabolic process (GO:0008206) | 4.94221783 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.84182856 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.84051210 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.79256267 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.79256267 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.79256267 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.77705237 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.77419632 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.72904871 |
| 43 | regulation of protein activation cascade (GO:2000257) | 4.72610140 |
| 44 | phospholipid efflux (GO:0033700) | 4.70167612 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.64592888 |
| 46 | glycine metabolic process (GO:0006544) | 4.58371794 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.55647083 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.55647083 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.55526954 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.52247686 |
| 51 | lysine metabolic process (GO:0006553) | 4.47185398 |
| 52 | lysine catabolic process (GO:0006554) | 4.47185398 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.46445360 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.46445360 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.40929394 |
| 56 | regulation of complement activation (GO:0030449) | 4.37380537 |
| 57 | aldehyde catabolic process (GO:0046185) | 4.37162478 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.33925682 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.28516324 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 4.25602923 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.25466565 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.25261720 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.24143912 |
| 64 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.23541178 |
| 65 | amine catabolic process (GO:0009310) | 4.20811040 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.20811040 |
| 67 | cholesterol efflux (GO:0033344) | 4.19668453 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 4.15381874 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.14657585 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.13359642 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10687979 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 4.08760537 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 4.07024127 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 4.04093945 |
| 75 | ethanol oxidation (GO:0006069) | 4.01557289 |
| 76 | cellular glucuronidation (GO:0052695) | 4.00728018 |
| 77 | amino sugar catabolic process (GO:0046348) | 3.96377003 |
| 78 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94693296 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.93920085 |
| 80 | glutamate metabolic process (GO:0006536) | 3.91085897 |
| 81 | drug catabolic process (GO:0042737) | 3.89761319 |
| 82 | microglial cell activation (GO:0001774) | 3.87995031 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86521571 |
| 84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86521571 |
| 85 | arginine metabolic process (GO:0006525) | 3.86290430 |
| 86 | fibrinolysis (GO:0042730) | 3.81164068 |
| 87 | NAD biosynthetic process (GO:0009435) | 3.79955340 |
| 88 | cofactor catabolic process (GO:0051187) | 3.79749940 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.78348983 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77045755 |
| 91 | ketone body metabolic process (GO:1902224) | 3.74515959 |
| 92 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.72727588 |
| 93 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.72727588 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.72317740 |
| 95 | organic acid catabolic process (GO:0016054) | 3.72317740 |
| 96 | cholesterol homeostasis (GO:0042632) | 3.71873106 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.71750819 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.70870908 |
| 99 | plasma lipoprotein particle organization (GO:0071827) | 3.69731795 |
| 100 | exogenous drug catabolic process (GO:0042738) | 3.67635382 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.66286582 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.65822888 |
| 103 | positive regulation of histone deacetylation (GO:0031065) | 3.65754404 |
| 104 | sterol homeostasis (GO:0055092) | 3.65528914 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.65104397 |
| 106 | protein-lipid complex assembly (GO:0065005) | 3.61986070 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.60059886 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.60059886 |
| 109 | carnitine metabolic process (GO:0009437) | 3.58076049 |
| 110 | reactive oxygen species biosynthetic process (GO:1903409) | 3.54624159 |
| 111 | flavonoid metabolic process (GO:0009812) | 3.54095146 |
| 112 | protein activation cascade (GO:0072376) | 3.53853155 |
| 113 | response to nitrosative stress (GO:0051409) | 3.51011208 |
| 114 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.48365106 |
| 115 | regulation of growth of symbiont in host (GO:0044126) | 3.48365106 |
| 116 | negative regulation of growth of symbiont in host (GO:0044130) | 3.48365106 |
| 117 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.48365106 |
| 118 | monocarboxylic acid catabolic process (GO:0072329) | 3.47868889 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.46593565 |
| 120 | omega-hydroxylase P450 pathway (GO:0097267) | 3.44960579 |
| 121 | neutrophil mediated immunity (GO:0002446) | 3.26617682 |
| 122 | heme biosynthetic process (GO:0006783) | 3.22809091 |
| 123 | heme metabolic process (GO:0042168) | 3.12906984 |
| 124 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.06571233 |
| 125 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.06558459 |
| 126 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04455406 |
| 127 | positive regulation of hemostasis (GO:1900048) | 2.96058112 |
| 128 | positive regulation of blood coagulation (GO:0030194) | 2.96058112 |
| 129 | S-adenosylmethionine metabolic process (GO:0046500) | 2.95033900 |
| 130 | positive regulation of protein deacetylation (GO:0090312) | 2.93381978 |
| 131 | thrombin receptor signaling pathway (GO:0070493) | 2.92774541 |
| 132 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.91790580 |
| 133 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90316640 |
| 134 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90316640 |
| 135 | modulation by symbiont of host immune response (GO:0052553) | 2.90316640 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90316640 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.90316640 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90316640 |
| 139 | regulation of chemokine biosynthetic process (GO:0045073) | 2.88943633 |
| 140 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.88269973 |
| 141 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.87872725 |
| 142 | centriole replication (GO:0007099) | 2.87002986 |
| 143 | positive regulation of coagulation (GO:0050820) | 2.84879607 |
| 144 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83926242 |
| 145 | negative regulation of phagocytosis (GO:0050765) | 2.81077213 |
| 146 | negative regulation of protein activation cascade (GO:2000258) | 2.79276212 |
| 147 | porphyrin-containing compound metabolic process (GO:0006778) | 2.76430221 |
| 148 | disruption of cells of other organism (GO:0044364) | 2.76192472 |
| 149 | killing of cells of other organism (GO:0031640) | 2.76192472 |
| 150 | macrophage activation (GO:0042116) | 2.70181844 |
| 151 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64630391 |
| 152 | response to peptidoglycan (GO:0032494) | 2.62148457 |
| 153 | neutrophil activation (GO:0042119) | 2.59286243 |
| 154 | protein-lipid complex subunit organization (GO:0071825) | 2.58471638 |
| 155 | respiratory burst (GO:0045730) | 2.56030975 |
| 156 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.54754889 |
| 157 | negative regulation of hemostasis (GO:1900047) | 2.54378512 |
| 158 | negative regulation of blood coagulation (GO:0030195) | 2.54378512 |
| 159 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50311149 |
| 160 | negative regulation of cell killing (GO:0031342) | 2.50311149 |
| 161 | base-excision repair, AP site formation (GO:0006285) | 2.49336424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.03639483 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.97599898 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.85072316 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09434650 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20939117 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.98364810 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.92310163 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.18846414 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.52429380 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48268482 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.15635012 |
| 12 | GATA1_19941826_ChIP-Seq_K562_Human | 2.15408528 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07049242 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04099263 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01483416 |
| 16 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3914220 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97903038 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96621089 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91510486 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90345700 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75635840 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68403325 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58040841 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55616564 |
| 25 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.51997015 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49492422 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47888638 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45730974 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.42992245 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42533347 |
| 31 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40519031 |
| 32 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39382171 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39053223 |
| 34 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37529642 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36377295 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35755666 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30789053 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30693876 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.29102825 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28265763 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28228410 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.26494439 |
| 43 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.25300885 |
| 44 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23654617 |
| 45 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23416468 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22286483 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21952335 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21762120 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21663388 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.20042495 |
| 51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13082274 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12492779 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10925724 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08990516 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08514439 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07920214 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04752328 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97514872 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96384404 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95745979 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94849043 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92579416 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92331064 |
| 64 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91453533 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90921995 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90366551 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89464286 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.89381211 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88256433 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88107426 |
| 71 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87888380 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87259154 |
| 73 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86977487 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86877325 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86623313 |
| 76 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86288775 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86217513 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84266497 |
| 79 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84071079 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83610505 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83470590 |
| 82 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83161863 |
| 83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82946883 |
| 84 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.81364280 |
| 85 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81043794 |
| 86 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80600711 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80538341 |
| 88 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80255983 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78882745 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76745396 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.75875998 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75156549 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71814637 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71804555 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.71676890 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.71298096 |
| 97 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.70867295 |
| 98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68884926 |
| 99 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68211486 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67123704 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65064944 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63921398 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63365240 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.63043897 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.62987815 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62833282 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.62421453 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62312171 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.62299683 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61434964 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.59445489 |
| 112 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59417457 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59187177 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58982709 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.57284615 |
| 116 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.56678529 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55788738 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55302990 |
| 119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.53430617 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53052188 |
| 121 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.52966576 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.50160027 |
| 123 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49906823 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.49861574 |
| 125 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48462683 |
| 126 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47857906 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47838678 |
| 128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47440015 |
| 129 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47313855 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46555528 |
| 131 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46142772 |
| 132 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.45311111 |
| 133 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.45113689 |
| 134 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.44833159 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.44730457 |
| 136 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.43910198 |
| 137 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.43854083 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.43854040 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.43613889 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42178494 |
| 141 | P300_27268052_Chip-Seq_Bcells_Human | 0.42027103 |
| 142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.41996846 |
| 143 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41900084 |
| 144 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.41136560 |
| 145 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40596215 |
| 146 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.40497933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21846527 |
| 2 | MP0005360_urolithiasis | 7.16949200 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.02482955 |
| 4 | * MP0005365_abnormal_bile_salt | 5.92825843 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02134496 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.13012564 |
| 7 | * MP0003252_abnormal_bile_duct | 3.52684164 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.46152288 |
| 9 | MP0009840_abnormal_foam_cell | 3.40370721 |
| 10 | MP0003195_calcinosis | 2.70084633 |
| 11 | MP0005332_abnormal_amino_acid | 2.66978934 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.52612967 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.46724237 |
| 14 | MP0003303_peritoneal_inflammation | 2.35226429 |
| 15 | * MP0005083_abnormal_biliary_tract | 2.27477179 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.26815356 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.17654880 |
| 18 | MP0000609_abnormal_liver_physiology | 2.17511607 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.00651388 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.89650234 |
| 21 | MP0003868_abnormal_feces_composition | 1.84319250 |
| 22 | MP0009697_abnormal_copulation | 1.81228760 |
| 23 | MP0005451_abnormal_body_composition | 1.78538856 |
| 24 | MP0001764_abnormal_homeostasis | 1.77572543 |
| 25 | MP0008004_abnormal_stomach_pH | 1.68625654 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.66062930 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.64434494 |
| 28 | MP0003186_abnormal_redox_activity | 1.59393331 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57488704 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.44333557 |
| 31 | MP0003011_delayed_dark_adaptation | 1.43849889 |
| 32 | MP0005671_abnormal_response_to | 1.42285659 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.41605648 |
| 34 | MP0008058_abnormal_DNA_repair | 1.41188536 |
| 35 | * MP0002452_abnormal_antigen_presenting | 1.38240510 |
| 36 | MP0002723_abnormal_immune_serum | 1.37188576 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.36275252 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.32760566 |
| 39 | MP0000343_altered_response_to | 1.30775987 |
| 40 | MP0009764_decreased_sensitivity_to | 1.30417910 |
| 41 | * MP0001819_abnormal_immune_cell | 1.30004503 |
| 42 | * MP0002420_abnormal_adaptive_immunity | 1.29342922 |
| 43 | * MP0000598_abnormal_liver_morphology | 1.25002424 |
| 44 | MP0001790_abnormal_immune_system | 1.24867756 |
| 45 | MP0005387_immune_system_phenotype | 1.24867756 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.21792016 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.19785080 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.16957238 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.16957238 |
| 50 | MP0008469_abnormal_protein_level | 1.12806608 |
| 51 | MP0009763_increased_sensitivity_to | 1.12376086 |
| 52 | MP0003828_pulmonary_edema | 1.11824669 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.10085154 |
| 54 | MP0005647_abnormal_sex_gland | 1.09665768 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.09497279 |
| 56 | MP0002398_abnormal_bone_marrow | 1.09489789 |
| 57 | MP0002722_abnormal_immune_system | 1.08424795 |
| 58 | MP0004147_increased_porphyrin_level | 1.03044588 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.01127619 |
| 60 | MP0000716_abnormal_immune_system | 1.00913173 |
| 61 | MP0002429_abnormal_blood_cell | 1.00215182 |
| 62 | MP0004043_abnormal_pH_regulation | 1.00192078 |
| 63 | MP0002254_reproductive_system_inflammat | 0.98672643 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.98109267 |
| 65 | MP0003436_decreased_susceptibility_to | 0.97571520 |
| 66 | MP0000604_amyloidosis | 0.96331537 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.95046098 |
| 68 | MP0002405_respiratory_system_inflammati | 0.93067773 |
| 69 | MP0009642_abnormal_blood_homeostasis | 0.91170144 |
| 70 | MP0005408_hypopigmentation | 0.90647742 |
| 71 | MP0008260_abnormal_autophagy | 0.90182728 |
| 72 | MP0003724_increased_susceptibility_to | 0.86388567 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.86045248 |
| 74 | MP0005310_abnormal_salivary_gland | 0.85949281 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.84337405 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82262670 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.81984954 |
| 78 | MP0006054_spinal_hemorrhage | 0.80731503 |
| 79 | MP0010368_abnormal_lymphatic_system | 0.80198505 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.79263928 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.78220994 |
| 82 | MP0005164_abnormal_response_to | 0.77943597 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.75791571 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.71053594 |
| 85 | MP0001663_abnormal_digestive_system | 0.69130060 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.68906324 |
| 87 | MP0005334_abnormal_fat_pad | 0.68087533 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.67830330 |
| 89 | MP0005266_abnormal_metabolism | 0.67279193 |
| 90 | MP0005670_abnormal_white_adipose | 0.64880748 |
| 91 | MP0009785_altered_susceptibility_to | 0.63417718 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 0.63168697 |
| 93 | MP0002971_abnormal_brown_adipose | 0.62914513 |
| 94 | MP0002928_abnormal_bile_duct | 0.61713840 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.61585974 |
| 96 | MP0006082_CNS_inflammation | 0.61570318 |
| 97 | MP0001853_heart_inflammation | 0.61502305 |
| 98 | MP0001756_abnormal_urination | 0.59389541 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.59015658 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.58487675 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.56919705 |
| 102 | MP0005025_abnormal_response_to | 0.56415807 |
| 103 | MP0008873_increased_physiological_sensi | 0.54972302 |
| 104 | MP0005535_abnormal_body_temperature | 0.53751634 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.53344151 |
| 106 | * MP0002419_abnormal_innate_immunity | 0.52945096 |
| 107 | MP0009053_abnormal_anal_canal | 0.51597303 |
| 108 | MP0004130_abnormal_muscle_cell | 0.51515164 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.51132104 |
| 110 | MP0001661_extended_life_span | 0.50506882 |
| 111 | MP0005448_abnormal_energy_balance | 0.49165290 |
| 112 | MP0003718_maternal_effect | 0.48912276 |
| 113 | MP0000685_abnormal_immune_system | 0.48245035 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.46560379 |
| 115 | MP0002132_abnormal_respiratory_system | 0.44193774 |
| 116 | MP0005395_other_phenotype | 0.43426501 |
| 117 | MP0003690_abnormal_glial_cell | 0.43295473 |
| 118 | MP0000249_abnormal_blood_vessel | 0.42051753 |
| 119 | MP0003075_altered_response_to | 0.41974057 |
| 120 | MP0008874_decreased_physiological_sensi | 0.41176843 |
| 121 | MP0009115_abnormal_fat_cell | 0.39808509 |
| 122 | MP0008872_abnormal_physiological_respon | 0.38840525 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.37911627 |
| 124 | MP0004947_skin_inflammation | 0.36766611 |
| 125 | MP0005166_decreased_susceptibility_to | 0.36628831 |
| 126 | MP0004381_abnormal_hair_follicle | 0.36031707 |
| 127 | MP0001800_abnormal_humoral_immune | 0.35482534 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.35463242 |
| 129 | MP0003953_abnormal_hormone_level | 0.34938094 |
| 130 | MP0009672_abnormal_birth_weight | 0.33451249 |
| 131 | MP0001243_abnormal_dermal_layer | 0.33013434 |
| 132 | MP0002970_abnormal_white_adipose | 0.32086367 |
| 133 | MP0002135_abnormal_kidney_morphology | 0.29145090 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.27299508 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.27218871 |
| 136 | MP0002796_impaired_skin_barrier | 0.27190381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.38702387 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.89073101 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.80286908 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44808155 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.22000413 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.17393851 |
| 7 | Xanthomatosis (HP:0000991) | 5.99003771 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.30382361 |
| 9 | Joint hemorrhage (HP:0005261) | 4.89398260 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.55753480 |
| 11 | Hyperammonemia (HP:0001987) | 4.54097300 |
| 12 | Complement deficiency (HP:0004431) | 4.52066820 |
| 13 | Prolonged bleeding time (HP:0003010) | 4.39516792 |
| 14 | Epidermoid cyst (HP:0200040) | 4.31937987 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.19830173 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19654280 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14083673 |
| 18 | Hyperglycinemia (HP:0002154) | 4.11847078 |
| 19 | Ketosis (HP:0001946) | 4.11217793 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10958001 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.10169485 |
| 22 | Petechiae (HP:0000967) | 4.08603682 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07170761 |
| 24 | Epistaxis (HP:0000421) | 4.05793318 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01397281 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.94491406 |
| 27 | Fat malabsorption (HP:0002630) | 3.92184038 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.89768727 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.84401776 |
| 30 | Purpura (HP:0000979) | 3.83892012 |
| 31 | Hyperglycinuria (HP:0003108) | 3.81695325 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.73175471 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73175471 |
| 34 | Abnormal platelet volume (HP:0011876) | 3.64734073 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63120642 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.56931073 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 3.56284841 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.47537713 |
| 39 | Obstructive lung disease (HP:0006536) | 3.47279816 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47279816 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.45171485 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.43458479 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41518782 |
| 44 | Impaired platelet aggregation (HP:0003540) | 3.38617729 |
| 45 | Abnormal platelet function (HP:0011869) | 3.38617729 |
| 46 | Abnormality of complement system (HP:0005339) | 3.37457654 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.22289975 |
| 48 | Myositis (HP:0100614) | 3.13959319 |
| 49 | Eczematoid dermatitis (HP:0000976) | 3.13598108 |
| 50 | Abnormality of macrophages (HP:0004311) | 3.12405571 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 3.02517037 |
| 52 | Steatorrhea (HP:0002570) | 3.02384599 |
| 53 | Delayed CNS myelination (HP:0002188) | 2.99937926 |
| 54 | Ketoacidosis (HP:0001993) | 2.90536410 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.85576577 |
| 56 | Orchitis (HP:0100796) | 2.84092056 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.82370275 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82370275 |
| 59 | Metabolic acidosis (HP:0001942) | 2.81890814 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.78350220 |
| 61 | Myocardial infarction (HP:0001658) | 2.76785689 |
| 62 | Optic neuritis (HP:0100653) | 2.74756379 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.74756379 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.72662197 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.70250981 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.70076274 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.67844372 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.66110133 |
| 69 | Spontaneous abortion (HP:0005268) | 2.63967148 |
| 70 | Lethargy (HP:0001254) | 2.62956264 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.61296732 |
| 72 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.61102029 |
| 73 | Polycythemia (HP:0001901) | 2.59060866 |
| 74 | Gangrene (HP:0100758) | 2.58795835 |
| 75 | Arterial thrombosis (HP:0004420) | 2.57963459 |
| 76 | Glomerulonephritis (HP:0000099) | 2.56615051 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.52563131 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52055582 |
| 79 | Menorrhagia (HP:0000132) | 2.51211198 |
| 80 | Acanthocytosis (HP:0001927) | 2.50330296 |
| 81 | Skin nodule (HP:0200036) | 2.49864875 |
| 82 | Spastic diplegia (HP:0001264) | 2.45546348 |
| 83 | Vascular calcification (HP:0004934) | 2.43588888 |
| 84 | Anorexia (HP:0002039) | 2.43323630 |
| 85 | Gingival bleeding (HP:0000225) | 2.43239033 |
| 86 | Increased serum ferritin (HP:0003281) | 2.40049929 |
| 87 | Cerebral edema (HP:0002181) | 2.36357010 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.35088469 |
| 89 | Opisthotonus (HP:0002179) | 2.29338146 |
| 90 | Irritability (HP:0000737) | 2.27269554 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.26559503 |
| 92 | Pancreatitis (HP:0001733) | 2.24600326 |
| 93 | Chest pain (HP:0100749) | 2.24358551 |
| 94 | Gout (HP:0001997) | 2.22924460 |
| 95 | Amyloidosis (HP:0011034) | 2.21911076 |
| 96 | Stomatitis (HP:0010280) | 2.21027201 |
| 97 | Cutaneous photosensitivity (HP:0000992) | 2.20547450 |
| 98 | Cholelithiasis (HP:0001081) | 2.20547162 |
| 99 | Thrombophlebitis (HP:0004418) | 2.19765718 |
| 100 | Esophageal varix (HP:0002040) | 2.19224763 |
| 101 | Renal cortical cysts (HP:0000803) | 2.19003533 |
| 102 | Malnutrition (HP:0004395) | 2.18435933 |
| 103 | Meningitis (HP:0001287) | 2.16201140 |
| 104 | Recurrent skin infections (HP:0001581) | 2.15334615 |
| 105 | Neonatal onset (HP:0003623) | 2.14845045 |
| 106 | Joint swelling (HP:0001386) | 2.13845188 |
| 107 | Late onset (HP:0003584) | 2.12666159 |
| 108 | Vomiting (HP:0002013) | 2.12454708 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 2.12230435 |
| 110 | Cholecystitis (HP:0001082) | 2.12230435 |
| 111 | Poikilocytosis (HP:0004447) | 2.11796542 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 2.10246517 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.09783016 |
| 114 | Brushfield spots (HP:0001088) | 2.09697689 |
| 115 | Nausea (HP:0002018) | 2.08561702 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07732737 |
| 117 | Hemoptysis (HP:0002105) | 2.07107937 |
| 118 | Mitral stenosis (HP:0001718) | 2.07049341 |
| 119 | Proximal tubulopathy (HP:0000114) | 2.01550642 |
| 120 | Urticaria (HP:0001025) | 2.00120724 |
| 121 | Reticulocytosis (HP:0001923) | 1.99586100 |
| 122 | Vasculitis (HP:0002633) | 1.99458146 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.99439142 |
| 124 | Episodic fever (HP:0001954) | 1.98725941 |
| 125 | Enlarged kidneys (HP:0000105) | 1.96779766 |
| 126 | Keratoconjunctivitis sicca (HP:0001097) | 1.96390275 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.95589474 |
| 128 | Glycosuria (HP:0003076) | 1.95589474 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.94961145 |
| 130 | Polyneuropathy (HP:0001271) | 1.94722478 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93704704 |
| 132 | Encephalitis (HP:0002383) | 1.91458781 |
| 133 | Sensorimotor neuropathy (HP:0007141) | 1.91248092 |
| 134 | Rickets (HP:0002748) | 1.89031384 |
| 135 | Abnormality of the gallbladder (HP:0005264) | 1.88528043 |
| 136 | Fair hair (HP:0002286) | 1.88217848 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.86765226 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86601986 |
| 139 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86468236 |
| 140 | Recurrent fungal infections (HP:0002841) | 1.84765039 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.84494485 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 1.83981381 |
| 143 | Hydroxyprolinuria (HP:0003080) | 1.83688404 |
| 144 | Abnormality of proline metabolism (HP:0010907) | 1.83688404 |
| 145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82378007 |
| 146 | Increased mean platelet volume (HP:0011877) | 1.82301845 |
| 147 | Gastrointestinal infarctions (HP:0005244) | 1.82097461 |
| 148 | Keratoconjunctivitis (HP:0001096) | 1.81492343 |
| 149 | Generalized hyperpigmentation (HP:0007440) | 1.81429920 |
| 150 | Pulmonary embolism (HP:0002204) | 1.80003435 |
| 151 | Conjunctival telangiectasia (HP:0000524) | 1.77853431 |
| 152 | Paralysis (HP:0003470) | 1.77734297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.74877505 |
| 2 | CCNB1 | 4.74178248 |
| 3 | ERN1 | 4.40105988 |
| 4 | NEK2 | 4.35800793 |
| 5 | SIK1 | 3.56115804 |
| 6 | FGFR4 | 3.53042258 |
| 7 | RIPK4 | 3.41479769 |
| 8 | TAOK3 | 3.34358616 |
| 9 | FLT3 | 2.78031998 |
| 10 | CAMKK2 | 2.52058485 |
| 11 | INSRR | 2.39859430 |
| 12 | PKN2 | 2.27967069 |
| 13 | TYK2 | 2.13375217 |
| 14 | TESK2 | 2.11931412 |
| 15 | SMG1 | 1.97318998 |
| 16 | MST1R | 1.80416304 |
| 17 | KDR | 1.78233382 |
| 18 | MAP2K3 | 1.76317772 |
| 19 | PIK3CG | 1.72904476 |
| 20 | MAPK11 | 1.69803008 |
| 21 | ERBB4 | 1.67658869 |
| 22 | NEK9 | 1.67504623 |
| 23 | TBK1 | 1.65486726 |
| 24 | IRAK3 | 1.63925611 |
| 25 | MAP3K14 | 1.63274279 |
| 26 | TAF1 | 1.55143057 |
| 27 | BLK | 1.50726838 |
| 28 | BMX | 1.46970115 |
| 29 | BMPR2 | 1.46251291 |
| 30 | ABL2 | 1.45960993 |
| 31 | VRK2 | 1.43723740 |
| 32 | MAP2K4 | 1.43141451 |
| 33 | CSF1R | 1.41330212 |
| 34 | FGR | 1.39105578 |
| 35 | MAP4K1 | 1.36550389 |
| 36 | TGFBR2 | 1.34492576 |
| 37 | MAP3K10 | 1.34424134 |
| 38 | FES | 1.33588150 |
| 39 | MAP4K2 | 1.22616847 |
| 40 | CAMK1G | 1.22545471 |
| 41 | KIT | 1.19322389 |
| 42 | PTK6 | 1.18711933 |
| 43 | FRK | 1.18549126 |
| 44 | MAP3K11 | 1.17323236 |
| 45 | GRK6 | 1.17240131 |
| 46 | JAK2 | 1.16124456 |
| 47 | MST4 | 1.15649984 |
| 48 | MAP2K6 | 1.14657216 |
| 49 | TNK2 | 1.09444230 |
| 50 | BTK | 1.06506143 |
| 51 | MAPK4 | 1.06356581 |
| 52 | TRIB3 | 1.04497616 |
| 53 | HCK | 1.03817734 |
| 54 | JAK3 | 1.03581168 |
| 55 | NUAK1 | 1.01998930 |
| 56 | IKBKE | 1.01714027 |
| 57 | NME2 | 1.01120078 |
| 58 | PTK2B | 0.95542332 |
| 59 | MAP3K3 | 0.90899734 |
| 60 | TIE1 | 0.90697942 |
| 61 | JAK1 | 0.90528761 |
| 62 | CLK1 | 0.90416871 |
| 63 | STK16 | 0.89098835 |
| 64 | PRPF4B | 0.88995202 |
| 65 | PRKAA2 | 0.88231387 |
| 66 | ACVR1B | 0.87045834 |
| 67 | CDK6 | 0.86945198 |
| 68 | TEC | 0.85603363 |
| 69 | CSK | 0.84717917 |
| 70 | CDK4 | 0.84527610 |
| 71 | GRK1 | 0.84023605 |
| 72 | TAOK2 | 0.83644013 |
| 73 | IRAK4 | 0.81127605 |
| 74 | MAP3K7 | 0.80059104 |
| 75 | ZAP70 | 0.79016573 |
| 76 | ARAF | 0.77087604 |
| 77 | YES1 | 0.73947688 |
| 78 | IKBKB | 0.73826837 |
| 79 | KSR2 | 0.72371068 |
| 80 | PAK4 | 0.70738173 |
| 81 | PINK1 | 0.69011024 |
| 82 | RAF1 | 0.67912119 |
| 83 | MAP3K1 | 0.67622035 |
| 84 | MAP3K2 | 0.66912004 |
| 85 | DYRK1B | 0.64415279 |
| 86 | MAPK15 | 0.62832319 |
| 87 | LYN | 0.61316784 |
| 88 | TGFBR1 | 0.60443230 |
| 89 | MAP3K6 | 0.59112114 |
| 90 | IRAK1 | 0.59096328 |
| 91 | ERBB2 | 0.58180871 |
| 92 | EIF2AK1 | 0.57600323 |
| 93 | PRKACG | 0.57444495 |
| 94 | MAP3K5 | 0.57054661 |
| 95 | MAPK12 | 0.56716995 |
| 96 | PDPK1 | 0.55534271 |
| 97 | MARK3 | 0.52442019 |
| 98 | WNK4 | 0.52400529 |
| 99 | ADRBK2 | 0.52216711 |
| 100 | DAPK2 | 0.52015153 |
| 101 | LATS1 | 0.51912745 |
| 102 | PRKCZ | 0.50741502 |
| 103 | STK10 | 0.49727792 |
| 104 | ICK | 0.49077662 |
| 105 | PIM1 | 0.46145753 |
| 106 | CHUK | 0.45473006 |
| 107 | PBK | 0.45192357 |
| 108 | RPS6KA4 | 0.44947714 |
| 109 | SYK | 0.44677217 |
| 110 | GSK3A | 0.44462162 |
| 111 | STK38L | 0.44450114 |
| 112 | GRK5 | 0.44343906 |
| 113 | STK4 | 0.44210787 |
| 114 | PIM2 | 0.44114706 |
| 115 | TLK1 | 0.43760015 |
| 116 | IGF1R | 0.43656880 |
| 117 | PDK1 | 0.42799711 |
| 118 | PRKCQ | 0.41728610 |
| 119 | CAMK1D | 0.41222075 |
| 120 | PDK2 | 0.39364347 |
| 121 | ITK | 0.38854619 |
| 122 | MAP2K2 | 0.37312483 |
| 123 | EIF2AK2 | 0.35755018 |
| 124 | ZAK | 0.35412211 |
| 125 | MATK | 0.35152878 |
| 126 | TXK | 0.34443368 |
| 127 | PRKG2 | 0.32229770 |
| 128 | EPHB1 | 0.32126730 |
| 129 | PRKAA1 | 0.32038021 |
| 130 | SRPK1 | 0.32021417 |
| 131 | EGFR | 0.30677992 |
| 132 | SGK3 | 0.29773288 |
| 133 | MAP3K13 | 0.29747277 |
| 134 | MET | 0.29541630 |
| 135 | FGFR3 | 0.28572751 |
| 136 | LRRK2 | 0.28493427 |
| 137 | BRAF | 0.28271829 |
| 138 | LCK | 0.28146557 |
| 139 | ABL1 | 0.27494647 |
| 140 | STK3 | 0.27307232 |
| 141 | MAP3K8 | 0.27186532 |
| 142 | PRKCD | 0.25710211 |
| 143 | MAPKAPK2 | 0.25309908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34760270 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46065701 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09654461 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07022428 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.80923431 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80831443 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68951049 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.58504621 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56601413 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52861619 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46368077 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46126413 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39381531 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.16628613 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12357854 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05411617 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97394605 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96116517 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94356232 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94234617 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89482576 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.88103871 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87709351 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85882975 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83873062 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83194681 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74456152 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71915101 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68337387 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66957307 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59925651 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54488936 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53304331 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52076111 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49053871 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48619188 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40954006 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36979792 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33914858 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32104240 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.31981001 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29708253 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29428577 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25630083 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.21510366 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20339719 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17643583 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16192043 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15017796 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11818340 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11178791 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07635532 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06656832 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.05425789 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99184734 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98584150 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97135431 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96701904 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93717533 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91237525 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.88350376 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.84961501 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80907948 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78555416 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76817741 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76358846 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74197176 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72320098 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67510747 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.66104553 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65681472 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64175128 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58509379 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57299060 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.57146125 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55144316 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53358027 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51489793 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51004918 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50498646 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47626619 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47511319 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.46784867 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46776861 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.41713112 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40321752 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40186850 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35354123 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33330404 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.30961207 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30205291 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29528147 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29326061 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28008729 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21653071 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18762668 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.17943358 |
| 98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11519895 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.06901491 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05577517 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05208002 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03118680 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02598453 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.02500544 |
| 105 | Malaria_Homo sapiens_hsa05144 | -0.1962862 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1945960 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1940845 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1874339 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1845031 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1733336 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1721510 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.1563283 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1352946 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1243267 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1143952 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1113029 |
| 117 | Pertussis_Homo sapiens_hsa05133 | -0.1030975 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0914475 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0587269 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | -0.0468264 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0408663 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0323992 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0253789 |

